Please use this identifier to cite or link to this item: https://hdl.handle.net/10137/5535
Full metadata record
DC FieldValueLanguage
dc.contributor.authorCommons RJen
dc.contributor.authorGrivas Ren
dc.contributor.authorCurrie BJen
dc.date.accessioned2018-05-15T23:01:07Zen
dc.date.available2018-05-15T23:01:07Zen
dc.date.issued2014-12en
dc.identifier.citationInternal medicine journal 2014-12; 44(12a): 1245-6en
dc.identifier.urihttps://hdl.handle.net/10137/5535en
dc.description.abstractMelioidosis is caused by the environmental bacterium Burkholderia pseudomallei and can present with severe sepsis. Predisposing risk factors are present in 80% of cases. Monoclonal antibodies are increasingly prescribed for varied medical conditions. This report describes the first known case of melioidosis in a patient whose only risk factor for disease is treatment with a monoclonal antibody. Prescribers of monoclonal antibodies and other immunosuppressants should ensure that their patients are aware of the potential risk of melioidosis prior to travel and the precautions that should be taken.en
dc.language.isoengen
dc.subjectBurkholderia pseudomalleien
dc.subjectimmunosuppressionen
dc.subjectmelioidosisen
dc.subjectmonoclonal antibodyen
dc.subjectpsoriatic arthritisen
dc.titleMelioidosis in a patient on monoclonal antibody therapy for psoriatic arthritis.en
dc.typeCase Reportsen
dc.typeJournal Articleen
dc.identifier.journaltitleInternal medicine journalen
dc.identifier.doi10.1111/imj.12610en
dc.identifier.pubmedidhttps://www.ezpdhcs.nt.gov.au/login?url=https://www.ncbi.nlm.nih.gov/pubmed//25442759en
dc.subject.meshAdalimumaben
dc.subject.meshAmoxicillin-Potassium Clavulanate Combinationen
dc.subject.meshAnti-Infective Agentsen
dc.subject.meshAntibodies, Monoclonal, Humanizeden
dc.subject.meshAntirheumatic Agentsen
dc.subject.meshArthritis, Psoriaticen
dc.subject.meshBurkholderia pseudomalleien
dc.subject.meshHumansen
dc.subject.meshMaleen
dc.subject.meshMelioidosisen
dc.subject.meshMiddle Ageden
dc.subject.meshRisk Factorsen
dc.subject.meshTreatment Outcomeen
dc.subject.meshTrimethoprim, Sulfamethoxazole Drug Combinationen
dc.identifier.affiliationDepartment of Infectious Diseases and Northern Territory Medical Program, Royal Darwin Hospital, Darwin, Northern Territory, Australia..en
Appears in Collections:(a) NT Health Research Collection

Files in This Item:
There are no files associated with this item.
Show simple item record


Items in ePublications are protected by copyright, with all rights reserved, unless otherwise indicated.

Google Media

Google ScholarTM

Who's citing